ArticleBMC rheumatology2019

Serum levels of reactive oxygen metabolites at 12 weeks during tocilizumab therapy are predictive of 52 weeks-disease activity score-remission in patients with rheumatoid arthritis.

Arata Nakajima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.